Clinical implications of receptor sensitivity modification.
D000928:Antidepressive Agents / Q000627:therapeutic use; D001679:Biogenic Amines / Q000378:metabolism*; D001696:Biomechanical Phenomena; D004298:Dopamine / Q000502:physiology; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011619:Psychotropic Drugs / Q000009:adverse effects; D011955:Receptors, Drug / Q000187:drug effects / Q000502:physiology*; D012559:Schizophrenia / Q000188:drug therapy; D005879:Tourette Syndrome / Q000188:drug therapy
D000928:Antidepressive Agents; D001679:Biogenic Amines; D011619:Psychotropic Drugs; D011955:Receptors, Drug; D004298:Dopamine